What this means
This study is recruiting patients and has not reported results yet. It will compare two methods for predicting death or new disability six months after surgery.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 55–110
- Where
- 4 sites
The science
- Registered title
- Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients
- Trial ID
- NCT05738252 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Gynecologic Cancer, Frailty, Oncology
- What is tested
- Clinical Frailty Scale, Frailty Phenotype
- Sponsor
- Population Health Research Institute
- Ages
- 55 Years to 110 Years
- Dates
- First posted Feb 22, 2023 · updated Apr 16, 2025
Registry summary
FARGO is a prospective cohort study that aims to determine the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery in patients aged 55 or older. Patients will have confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.
Sites (4)
- Juravinksi Hospital, Hamilton, Ontario, Canada
- Credit Valley Hospital, Mississauga, Ontario, Canada
- Sunnybrook, Toronto, Ontario, Canada
- University Health Network, Toronto, Ontario, Canada